Flex Slides 27% in a Month as Spinoff Uncertainty Bites
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Flex Ltd. has dropped sharply over the past month, shedding 27% to close at $83.35 on October 27, even as an 8.3% bounce on Tuesday offered a brief reprieve. The stock is down 4.7% on the week, lagging most of its closest peers: JBL added 2.2% over the same period, CGNX gained 2.6%, and CTS rose 7%. The selloff has brought Flex from a post-spinoff peak of around $167 to levels not seen since before the initial excitement around the planned separation of its Axiom Solutions business.
Short sellers have not been the primary driver of this move. Short interest stands at 2.1% of the free float, a low reading by most standards, and it has fallen 12% over the past week and 20% over the past month, with around 7.7 million shares short as of October 27. Borrowing costs are equally subdued at 0.48%, little changed over the past 30 days. Availability is extremely loose, with far more shares available to borrow than are currently lent out, and the lending pool has been in this state throughout October. Options positioning is similarly relaxed. The put/call ratio sits at 0.44, essentially in line with its 20-day average of 0.44, and the z-score is flat at -0.15. There is no evidence that the market is positioning aggressively for further downside through either the lending or derivatives market.
The Street, however, remains meaningfully more constructive than the current price implies. The mean analyst price target is $155.90, roughly 87% above Tuesday's close. That gap is unusually wide and reflects a series of target cuts rather than a stable view. Goldman Sachs and Barclays, both maintaining positive ratings, lowered their targets in late July, Goldman to $154 from $177 and Barclays to $144 from $203. Those moves followed Flex's fiscal first-quarter results, which were announced on October 21 and accompanied by a 12.3% single-day share-price decline. Freedom Capital Markets has maintained a $150 Buy rating as recently as late September. The forward earnings picture remains strong on paper: the 12-month forward earnings-per-share growth estimate ranks in the 92nd percentile of the universe, and near-term EPS momentum scores are elevated at the 82nd percentile on the 30-day window. The PE ratio has compressed to 12.1x, down sharply over the past 30 days, while the EV/EBITDA multiple sits near 7.2x. Those are undemanding multiples if the growth forecasts hold.
The central debate is about Axiom. The bear case, as reflected in analyst target cuts and the stock's price action, is that Flex's current valuation leans heavily on the timing and execution of the spinoff, and any delay or disappointment there removes the premium investors were willing to pay earlier in the year. The bull case rests on the Cloud and Power Infrastructure business, which management guided for 65%-plus growth in fiscal 2027 and 80% in fiscal 2028, with adjusted EBIT margins already running at 9.7% on roughly $8.8 billion in annualised sales. The $4.4 billion EPC Power acquisition sits at the centre of that thesis. ORTEX forecasts a 60% probability that Flex's share count in the Russell 1000 and Russell 3000 decreases as a result of the spinoff, with an estimated announcement in late March 2027 and an effective date of March 31, 2027. Those dates are estimated rather than confirmed.
Institutional ownership shifted through the summer in ways worth noting. BlackRock's 13G filing from late July showed its stake had fallen to 7.8% from 10.4%, while Vanguard entities collectively reshuffled their ownership structure following the spinoff announcement, with one Vanguard entity filing at zero percent in March before Vanguard Portfolio Management filed a fresh 13G at 5.27% in April. FMR, meanwhile, lifted its reported stake to 5.3% from 4.7% in an August filing. None of these are activist positions. Insider activity in the past 90 days has been modest in scale: the Chief Commercial Officer made a series of open-market sales in August worth roughly $299,000 in total, while director equity grants in September and October were small routine awards. Net insider selling over 90 days is a negligible 2,755 shares in value terms.
Wikipedia traffic for Flex is running 1.7 standard deviations above its own 90-day average as of October 19, the highest retail-attention reading in recent weeks, coinciding with the stock's sharp decline and the earnings announcement. The next scheduled earnings event is November 10.
Stocks in this article
See the live data behind this article on ORTEX.
Open FLEX on ORTEX →How this article was generated
- Generated
- 28 Oct 2026, 19:07
- Data as of
- 28 Oct 2026, 19:03
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.